The name of the issuer is AxonPrime Infrastructure Acquisition Corporation (the “Issuer”).
Item 1(b) | Address of Issuer’s Principal Executive Offices |
The Issuer’s principal executive offices are located at: 126 E. 56th St., 30th Floor, New York, NY 10022.
Item 2(a) | Name of Person Filing |
This Schedule 13G is being filed on behalf of the following persons (the “Reporting Persons”)*:
| (i) | FIG LLC, a Delaware limited liability company, indirectly controls investment advisors to certain investment funds (the “Funds”) that hold Issuer units, each consisting of one share of Common Stock and one-third of one redeemable, contingent warrant to purchase one share of Common Stock, and may therefore be deemed to beneficially own the Common Stock included in such units (the “Shares”); |
| | |
| (ii) | Fortress Operating Entity I LP, a Delaware limited partnership, directly or indirectly controls the general partners or sole members of the Funds, as applicable, and is the holder of all the issued and outstanding shares of FIG LLC, and may therefore be deemed to beneficially own the Shares; | |
| | | |
| (iii) | FIG Corp., a Delaware corporation, is the general partner of Fortress Operating Entity I LP and may therefore be deemed to beneficially own the Shares; and |
| | |
| (iv) | Fortress Investment Group LLC, a Delaware limited liability company, is the holder of all the issued and outstanding shares of FIG Corp. and may therefore be deemed to beneficially own the Shares. | |
The Joint Filing Agreement among the Reporting Persons to file this Schedule 13G jointly in accordance with Rule 13d-1(k) of the Exchange Act is attached as Exhibit A hereto.
Item 2(b) | Address of Principal Business Office or, if None, Residence |
The address of the principal business office of each of the Reporting Persons is: c/o Fortress Investment Group LLC, 1345 Avenue of the Americas, 46th Floor, New York, NY 10105.
See Item 4 of each of the cover pages.
Item 2(d) | Title of Class of Securities |
Class A Common Stock, par value $0.0001 per share.
No CUSIP number has been assigned to the Common Stock. The CUSIP number 05467C207 has been assigned to the Issuer units that each include one share of Common Stock.